Hexagon Bio
PrivateLast Round
Series B
Feb 13, 2023
Total Funding Raised
$132.6M
Company Overview
Hexagon Bio is a biotechnology company that utilizes a synthetic biology platform and data science to discover small molecule inhibitors from fungal genomes, facilitating the identification of new medicines to enhance patient care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexagon Bio Comparables
Compare Hexagon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeMine Therapeutics | 83% | |
| Bactobio | 80% | |
| Pragma Bio | 80% |
Hexagon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2023 | ||||
| VC Round | Sep 22, 2021 | ||||
| Series A | Sep 15, 2020 | ||||
| Seed | Jul 6, 2017 |
Hexagon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | VC Round, Series B, Series A |
| CPP Investments | Series B |
| SoftBank Investment Advisers | VC Round |
| SoftBank Group | VC Round |
| The Chernin Group | Series A |
| Two Sigma Ventures | VC Round, Seed, Series B, Series A |
| 8VC | VC Round, Seed, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Developing natural crop protections in partnership with Corteva.
- Dec 17, 2025
Partnered with Corteva to develop natural crop protections.
Hexagon Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hexagon Bio's valuation, stock price, and market status.
Is Hexagon Bio a public or private company?
Hexagon Bio is a private company.
What is the current stock price of Hexagon Bio?
Hexagon Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Hexagon Bio worth (valuation)?
Valuation information for Hexagon Bio is not publicly available.
Can I buy Hexagon Bio stock?
Hexagon Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hexagon Bio's last funding round?
Hexagon Bio's most recent funding round was Series B on February 13, 2023.
Who are the main investors in Hexagon Bio?
Key investors in Hexagon Bio include The Column Group, The Chernin Group, Two Sigma Ventures, Nextech Invest.
Will Hexagon Bio IPO soon?
No public IPO plans have been announced for Hexagon Bio.
How can I track Hexagon Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hexagon Bio's secondary market activity and sign up for updates.